Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma
Translational Andrology and Urology · 2023-09 · 12 (9) · 1456-1468
DOI: 10.21037/tau-23-45 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Andrology and Urology, 2023-09. Verfasst von Andrew J Zganjar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mayo Clinic, Jacksonville, FL, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
- Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Zganjar, A. J., Thiel, D. D., & Lyon, T. D. (2023). Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma. Translational Andrology and Urology, 12(9), 1456-1468. https://doi.org/10.21037/tau-23-45
Vancouver
Zganjar AJ, Thiel DD, Lyon TD. Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma. Translational Andrology and Urology. 2023;12(9):1456-1468. doi:10.21037/tau-23-45
BibTeX
@article{Zganjar2023,
author = {Zganjar, Andrew J and Thiel, David D and Lyon, Timothy D},
title = {Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma},
journal = {Translational Andrology and Urology},
year = {2023},
volume = {12},
number = {9},
pages = {1456--1468},
doi = {10.21037/tau-23-45}
}
EUVIMED